Your browser doesn't support javascript.
loading
COPD lung studies of Nrf2 expression and the effects of Nrf2 activators.
Li, Jian; Baker, James; Higham, Andrew; Shah, Rajesh; Montero-Fernandez, Angeles; Murray, Clare; Cooper, Nicky; Lucas, Cathy; Fox, Craig; Singh, Dave; Lea, Simon.
Afiliação
  • Li J; Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester and Manchester University NHS Foundation Trust, Manchester, UK.
  • Baker J; Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester and Manchester University NHS Foundation Trust, Manchester, UK.
  • Higham A; Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester and Manchester University NHS Foundation Trust, Manchester, UK.
  • Shah R; Department of Thoracic Surgery, Manchester University Hospital NHS Foundation Trust, Manchester, UK.
  • Montero-Fernandez A; Department of Histopathology, Manchester University Hospital NHS Foundation Trust, Manchester, UK.
  • Murray C; C4X Discovery Ltd, Manchester, UK.
  • Cooper N; C4X Discovery Ltd, Manchester, UK.
  • Lucas C; C4X Discovery Ltd, Manchester, UK.
  • Fox C; C4X Discovery Ltd, Manchester, UK.
  • Singh D; Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester and Manchester University NHS Foundation Trust, Manchester, UK.
  • Lea S; Medicines Evaluation Unit, Manchester University Hospital NHS Foundation Trust, The Langley Building, Southmoor Road, Manchester, UK.
Inflammopharmacology ; 30(4): 1431-1443, 2022 Aug.
Article em En | MEDLINE | ID: mdl-35441963

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença Pulmonar Obstrutiva Crônica / Fator 2 Relacionado a NF-E2 Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença Pulmonar Obstrutiva Crônica / Fator 2 Relacionado a NF-E2 Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article